Dolby Laboratories, Inc. ( NYSE:DLB ) investors will be delighted, with the company turning in some strong numbers ...
Data from the first 16 weeks of the open-label extension phase of the RewinD-LB trial are expected in 1Q 2025 and will include data from participan ...